Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00645203 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media
A Phase 2 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 2
- Development phase
- 447
- Enrollment target
NCT00645203: Completed Phase 2 study, sponsored by Abbott.
NCT00645203 is a Phase 2 study that has completed, run by Abbott. The registered enrollment target is 447 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (236% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00645203, a Phase 2 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 447 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of cefdinir oral suspension in children between 6 months and 4 years of age, with acute otitis media, who are at risk of persistent or recurrent otitis media.
Interventions
- DRUG cefdinir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 447 participants |
| Start Date | 2002-07 |
| Phase | Phase 2 |
What the finished NCT00645203 record still lists
NCT00645203 is an interventional study that assigns participants to a tested intervention. The registered 447 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (236% higher).
The record links to 0 conditions, and to 1 intervention - of which cefdinir is the first listed.
NCT00645203 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00645203 about?
NCT00645203 is a clinical study titled "Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media". To evaluate the safety and efficacy of cefdinir oral suspension in children between 6 months and 4 years of age, with acute otitis media, who are at risk of persistent or recurrent otitis media.
What is the current status of trial NCT00645203?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 447 participants. The study started on 2002-07.
What interventions are being tested in trial NCT00645203?
The interventions under investigation include: cefdinir (DRUG).
Who is sponsoring clinical trial NCT00645203?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00645203's enrollment target sits among peer trials
447 89th of 2000 higher than 1,912 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT06702449 · 448 participants · Phase 1
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
- NCT07125053 · 448 participants · NA
COPD Resources, Education, and Activity Designed for You Study
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia